MINNEAPOLIS—DaVita Clinical Research announced June 9 the company’s recent investment in its Central Laboratory, servicing pharmaceutical, biotechnology and medical device industries.
The investment was applied to analytical methodology, information technology (IT) and instrumentation in support of DCR’s continued drive to serve its clients. Over the past three years, DCR has had a strategic focus on Central Laboratory services, investing in state-of-the-art capital equipment, infrastructure and laboratory expansion/remodeling.
The Central Laboratory uses the latest in laboratory instrumentation to provide rapid, accurate results. Some examples of the lab’s instrumentation and test menu include:
- 7 Olympus 5400
- 17 Siemens Centaur
- 9 Tosoh G-8
- 2 Liaison Diasorin
- 8 Perkin-Elmer ICP-MS
- 2 Nova
- 2 Dianex
- 23 Siemens Advia 2120
- 2 TOPS Coagulation
- 19 BACTEC 9240
- 14 Lonza BioTek
- 4 Vitek-2
DCR’s Central Laboratory also has invested in such technology as centrifuges, auto samplers, slide strainers, incubators, biosafety cabinets and decappers. DCR’s investment assisted in expanding and remodeling the laboratory, adding significant space to help facilitate future service expansion. In addition, extensive investment in its Falcon Lab software application has resulted in the latest release.
At DCR’s Central Laboratory, individual trial samples are tracked using LabScope Online. Additional services include the new, innovative green packaging capabilities featuring a unique IATA-compliant, storage-friendly design, and the lab’s highly dedicated customer support team, which ensures most specimen turnaround time of 24 hours or less.
“DCR’s Florida-based Central Laboratory facility is one of the industry’s best kept secrets,” said DCR Vice President, Commercial Development Kevin J. Goudreau. “We are confident that, over time, our continued investments in both physical assets and an expanded assay list will position us to be a prominent player in the clinical trials support business.”
The DCR Central Laboratory team is led by medical technologists, medical technicians and clinical pathologists, and receives formal guidance from nephrologists in the industry.
